Postoperative pain after open abdominal hysterectomy
Conditions
Interventions
Trade Name: Chirocaine
Pharmaceutical Form: Solution for infusion
Concentration unit: mg/ml milligram(s)/millilitre
Concentration number: 1,25-
Pharmaceutical form of the placebo: Solution for infusio
Sponsors
Örebro University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 18 –65 year old patients undergoing open abdominal hysterectomy. ASA I – II Have signed and dated Informed Consent. Willing and able to comply with the protocol for the duration of the trial. Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: Patients undergoing open abdominal hysterectomy due to suspected cancer. Patients with chronic pain who are taking analgesics regularly. Allergy to components in levobupivacaine (Chirocaine)/Saline (Sodium Chloride). Participation in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Secondary Objective: Can efficient post-operative pain improved patient "outcome" following abdominal hysterectomy?;Primary end point(s): Total morphine consumption 0 – 24 h postoperatively.;Main Objective: Which method for administration of intraperitoneal local anesthetics gives the best pain relief and requires the lowest morphine consumption after abdominal hysterectomy, patient controlled administration (PCA) or continuous infusion. | — |
Countries
Sweden
Outcome results
None listed